IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF‐I
- 17 March 1992
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 36 (3), 301-304
- https://doi.org/10.1111/j.1365-2265.1992.tb01449.x
Abstract
Objective The aim of the study was to investigate the serum levels of IGFBP‐3, the major IGF‐I binding protein, in patients with Laron type dwarfism (LTD) before and after IGF‐I treatment design and patients Eight Laron type dwarfism patients (four children and four adults) were treated for 7 days by one daily s.c. injection of blosynthetic IGF‐I In doses of 120 or 150 μ g/kg/day. measurements Blood was sampled in the fasting state before and 1 and 7 days after the last Injection results It was found that IGF‐I administration significantly reduced plasma hGH levels with recovery after one week of no treatment. Serum IGFBP‐3 was abnormally low (0·70·0±37 mg/l) and decreased significantly further during IGF‐I treatment (to 0·48·0±28 mg/l) (P > 0·065). conclusions The finding that serum IGFBP‐3 is low in Laron type dwarfism, a disease due to molecular defects in the GH receptor, is compatible with the hypothesis that this IGF binding protein is GH‐dependent. On the other hand the decrease during IGF‐I administration and concomitant suppression of GH secretion may denote either that GH activity is not completely blocked in this syndrome or that there are additional mechanisms regulating IGFBP‐3 synthesisKeywords
This publication has 19 references indexed in Scilit:
- Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfismClinical Endocrinology, 1991
- Role of Growth-Hormone and Insulin-Like Growth-Factor-Binding ProteinsHormone Research, 1990
- Laron Dwarfism and Mutations of the Growth Hormone–Receptor GeneNew England Journal of Medicine, 1989
- Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.Proceedings of the National Academy of Sciences, 1989
- SERUM GROWTH HORMONE BINDING PROTEIN ACTIVITY IN HEALTHY NEONATES, CHILDREN AND YOUNG ADULTS: CORRELATION WITH AGE, HEIGHT AND WEIGHTClinical Endocrinology, 1989
- EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISMThe Lancet, 1988
- Growth hormone receptor and serum binding protein: purification, cloning and expressionNature, 1987
- Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma.JCI Insight, 1986
- INSULIN‐LIKE GROWTH FACTOR I (IGF‐I) IN HEALTHY CHILDREN, ADOLESCENTS AND ADULTS AS DETERMINED BY A RADIOIMMUNOASSAY SPECIFIC FOR THE SYNTHETIC 53–70 PEPTIDE REGIONClinical Endocrinology, 1986
- Chemical Synthesis, Cloning, and Expression of Genes for Human Somatomedin C (Insulin‐like Growth Factor I) and 59Val‐Somatomedin CAnnals of the New York Academy of Sciences, 1986